Digital China Health Technologies will team up with Congenica, a UK company, to market Congenica’s Sapientia™, a diagnostic decision support platform for genomics, to Chinahospitals. Congenica will develop a China-specific version of Sapientia, which will make the advances of genomics and personalized medicine available to clinicians. The company says its platform is particularly useful for diagnosing rare diseases. DCHealth is is the healthcare subsidiary of Digital China Holdings, a major China IT provider.
Source: China Biotoday
